{"id":"W2767600184","doi":"10.1056/nejmoa1701830","title":"20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years","year":2017,"lang":"en","type":"review","venue":"New England Journal of Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1810,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging; Medical Research Council; Rijksuniversiteit Groningen; University of Oxford; Massachusetts Medical Society; National Institute for Health and Care Research; British Heart Foundation; Cancer Research UK","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Proportional hazards model; Cancer; Endocrine system; Stage (stratigraphy); Disease; Gynecology; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1155099890975973,"score_gpt":0.416234974307602,"score_spread":0.3007249852100047,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}